Structure-based drug design with equivariant diffusion models.
Europe PMC REST API · 学术索引收录 · 来源发布：Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:13 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods leverage structural data of drugs with their protein targets to propose new drug candidates. However, most existing methods focus exclusively on bottom-up de novo design of compounds or tackle other drug development challen
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。